Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Accelerated atherosclerosis in prolonged maintenance hemodialysis.

× No keyword cloud information.

199 in total

1. Coronary artery bypass grafting in dialysis patients.

Authors: H Tanaka; K Suzuki; T Narisawa; T Ookura; Y Kamio; S Suzuki; A Kitami; T Suzuki; T Takaba
Journal: Jpn J Thorac Cardiovasc Surg Date: 2000-11

Review 2. Uremic toxins.

Authors: B D Cohen
Journal: Bull N Y Acad Med Date: 1975-12

Review 3. Atherosclerosis in CKD: differences from the general population.

Authors: Tilman B Drüeke; Ziad A Massy
Journal: Nat Rev Nephrol Date: 2010-10-26 Impact factor: 28.314

4. Minor renal dysfunction: an emerging independent cardiovascular risk factor.

Authors: E Ritz
Journal: Heart Date: 2003-09 Impact factor: 5.994

5. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension.

Authors: R L Converse; T N Jacobsen; C M Jost; R D Toto; P A Grayburn; T M Obregon; F Fouad-Tarazi; R G Victor
Journal: J Clin Invest Date: 1992-11 Impact factor: 14.808

Review 6. Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.

Authors: Alberto Ortiz; Ziad A Massy; Danilo Fliser; Bengt Lindholm; Andrzej Wiecek; Alberto Martínez-Castelao; Adrian Covic; David Goldsmith; Gültekin Süleymanlar; Gérard M London; Carmine Zoccali
Journal: Nat Rev Nephrol Date: 2011-11-01 Impact factor: 28.314

Accelerated atherosclerosis in prolonged maintenance hemodialysis.

1. Coronary artery bypass grafting in dialysis patients.

Review 2. Uremic toxins.

Review 3. Atherosclerosis in CKD: differences from the general population.

4. Minor renal dysfunction: an emerging independent cardiovascular risk factor.

5. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension.

Review 6. Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis.

7. Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo.

8. Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

9. Activation of platelets upon contact with a vitamin E-coated/non-coated surface.

10. Cardiac abnormalities and exercise tolerance in patients receiving renal replacement therapy.